REQUEST A DEMO
Total
USD $0.00
Search more companies

PT Global Pharma Indonesia (Indonesia)

Main Activities: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
Full name: PT Global Pharma Indonesia Profile Updated: February 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

PT Global Pharma Indonesia is a company based in Indonesia, with its head office in Tangerang. The company operates in the Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers sector. It was established on June 01, 2006. There was a net sales revenue increase of 13.14% reported in PT Global Pharma Indonesia’s latest financial highlights for 2022. Its’ total assets recorded a growth of 12.66%.

Headquarters
Pergudangan Lio Baru Asri Blok C1, RT 004 RW 001
Tangerang; Banten; Postal Code: 15122

Contact Details: Purchase the PT Global Pharma Indonesia report to view the information.

Basic Information
Outstanding Shares:
Purchase the PT Global Pharma Indonesia report to view the information.
Registered Capital:
Purchase the PT Global Pharma Indonesia report to view the information.
Incorporation Date:
June 01, 2006
Key Executives
Purchase this report to view the information.
President Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after PT Global Pharma Indonesia report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
13.14%
Total operating revenue
13.14%
Total assets
12.66%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?